Dual metformin and GLP-1 receptor agonist therapy was found to reduce death rates and hepatic adverse outcomes in diabetic patients with cirrhosis [54]
It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]
Estos productos no contienen medicamentos GLP-1 aprobados , carecen de ensayos clnicos slidos y suelen apoyarse en mensajes publicitarios engaosos
GLP-1 drugs are intended to be used over the long-term, to treat obesity as a chronic conditionnot in the short-term for a big event, says Ethan Lazarus, MD, an obesity medicine specialist in Denver, CO, and past president of the Obesity Medicine Association
In fact, studies in human cell lines and a murine model have actually demonstrated inhibition of tumor growth with liraglutide 30
Available from: Wang Y, Song X, Zhuang L, Lang H, Yu L, Yan X, et al